JP7607939B2 - 喘息を治療するための方法 - Google Patents
喘息を治療するための方法 Download PDFInfo
- Publication number
- JP7607939B2 JP7607939B2 JP2021574818A JP2021574818A JP7607939B2 JP 7607939 B2 JP7607939 B2 JP 7607939B2 JP 2021574818 A JP2021574818 A JP 2021574818A JP 2021574818 A JP2021574818 A JP 2021574818A JP 7607939 B2 JP7607939 B2 JP 7607939B2
- Authority
- JP
- Japan
- Prior art keywords
- asthma
- dapanstril
- airway
- mice
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962862434P | 2019-06-17 | 2019-06-17 | |
| US62/862,434 | 2019-06-17 | ||
| PCT/US2020/037696 WO2020257093A1 (en) | 2019-06-17 | 2020-06-15 | Method for treating asthma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022536932A JP2022536932A (ja) | 2022-08-22 |
| JP2022536932A5 JP2022536932A5 (https=) | 2023-06-22 |
| JP7607939B2 true JP7607939B2 (ja) | 2025-01-06 |
Family
ID=74040873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021574818A Active JP7607939B2 (ja) | 2019-06-17 | 2020-06-15 | 喘息を治療するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220087969A1 (https=) |
| EP (1) | EP3983070B1 (https=) |
| JP (1) | JP7607939B2 (https=) |
| CN (1) | CN114007690B (https=) |
| AU (1) | AU2020296829B2 (https=) |
| CA (1) | CA3141407A1 (https=) |
| MX (1) | MX2021015561A (https=) |
| WO (1) | WO2020257093A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2651407B1 (en) * | 2010-12-15 | 2016-12-21 | Olatec Industries LLC | 3-methanesulfonylpropionitrile for treating inflammation and pain |
| FR3046933B1 (fr) * | 2016-01-25 | 2018-03-02 | Galderma Research & Development | Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires |
| US11597706B2 (en) * | 2016-04-18 | 2023-03-07 | Novartis Ag | Compounds and compositions for treating conditions associated with NLRP activity |
-
2020
- 2020-06-15 AU AU2020296829A patent/AU2020296829B2/en active Active
- 2020-06-15 CA CA3141407A patent/CA3141407A1/en active Pending
- 2020-06-15 CN CN202080044814.9A patent/CN114007690B/zh active Active
- 2020-06-15 MX MX2021015561A patent/MX2021015561A/es unknown
- 2020-06-15 JP JP2021574818A patent/JP7607939B2/ja active Active
- 2020-06-15 WO PCT/US2020/037696 patent/WO2020257093A1/en not_active Ceased
- 2020-06-15 EP EP20826406.9A patent/EP3983070B1/en active Active
-
2021
- 2021-12-02 US US17/457,420 patent/US20220087969A1/en not_active Abandoned
Non-Patent Citations (3)
| Title |
|---|
| American Journal of Respiratory and Critical Care Medicine,2017年,Vol.196, No.3,p.283-297 |
| PNAS,2018年,Vol.115, No.7,E1530-1539 |
| Toxicology Siences,2019年04月,Vol.170, No.2,p.462-475 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114007690A (zh) | 2022-02-01 |
| JP2022536932A (ja) | 2022-08-22 |
| US20220087969A1 (en) | 2022-03-24 |
| AU2020296829B2 (en) | 2026-01-15 |
| CA3141407A1 (en) | 2020-12-24 |
| WO2020257093A1 (en) | 2020-12-24 |
| MX2021015561A (es) | 2022-01-24 |
| EP3983070B1 (en) | 2024-09-11 |
| AU2020296829A1 (en) | 2022-02-10 |
| EP3983070A4 (en) | 2023-04-26 |
| EP3983070A1 (en) | 2022-04-20 |
| CN114007690B (zh) | 2024-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6258816B1 (en) | Anti-allergy anti-inflammatory composition | |
| US20240245646A1 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| JP2005510535A (ja) | クロモリンナトリウムの経口投与用製剤 | |
| RU2685706C2 (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP7607939B2 (ja) | 喘息を治療するための方法 | |
| Hoshino et al. | Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma | |
| CN114796183B (zh) | 益母草碱在制备用于预防或治疗呼吸系统疾病的药物中的应用 | |
| CN105663152A (zh) | 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用 | |
| WO2024041633A1 (zh) | 一种稠环嘧啶类化合物的用途 | |
| CN100394981C (zh) | 一种人粒细胞巨噬细胞集落刺激因子喷雾剂及其制备方法 | |
| KR102410183B1 (ko) | 이소글리시리진산 또는 이의 염의 흡입용 제제, 및 호흡 기관 질환을 치료하기 위한 약물의 제조에서의 용도 | |
| CN101057877A (zh) | 草珊瑚提取方法、提取物及其药物组合物与用途 | |
| CN116712480B (zh) | 一种用于预防流行性感冒的药物组合物及其制剂和应用 | |
| US20240269104A1 (en) | Method for treating parkinson's disease | |
| Jonassen et al. | AP1189: A novel oral biased melanocortin agonist with anti-inflammatory and pro-resolving effect for the treatment of rheumatoid arthritis—ACR meeting abstracts | |
| CN112023027B (zh) | 胸腺素或其衍生物的应用和治疗快感缺乏型抑郁症的药物 | |
| JPH11106337A (ja) | 乾癬の処置剤 | |
| JP3428465B2 (ja) | 新規な抗アレルギー抗炎症組成物 | |
| CN120000665A (zh) | 雷公藤红素在制备防治ilc2细胞介导的过敏性肺部炎症药物中的应用 | |
| WO2025146212A1 (zh) | N-[2-[[[4-(2,2-二甲基-1-氧代丙氧基)苯基]磺酰]氨基]苯甲酰]-(s)-甘氨酸或其盐的新用途 | |
| WO2026007876A1 (zh) | Gpr84拮抗剂的用途 | |
| CN110251507A (zh) | 一种针对p物质引发的哮喘的药物应用 | |
| CN121003624A (zh) | 水杨酸在制备治疗和/或预防间质性肺疾病药物中的应用 | |
| CN118416039A (zh) | 3-环丙基甲氧基-4-(二氟甲氧基)苯甲酸在制备治疗肺部疾病的药物中的应用 | |
| CN115475176A (zh) | 罗汉果皂苷v在治疗溃疡性结肠炎药物中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230614 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230614 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240514 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240515 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240814 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20241112 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241211 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7607939 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |